About this item:

335 Views | 391 Downloads

Author Notes:

Correspondence to: Dr Carlos S. Moreno, Department of Pathology and Laboratory Medicine, Emory University School of Medicine, 615 Michael Street, Atlanta, GA 30322, USA E-mail: cmoreno@emory.edu

See publication for full list of author contributions.

The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

The funders had no role in the design of the study; in the collection, analyses, or interpretation of data, in the writing of the manuscript, and in the decision to publish the results.

The authors declare that they have no competing interests.

Subjects:

Research Funding:

The research reported in this publication was supported in part by the Emory Integrated Genomics Core (EIGC) Shared Resource of Winship Cancer Institute of Emory University and NIH/NCI under award number UL1TR002378.

This study was funded by NIH grant no. U01 CA217875-01.

Keywords:

  • Science & Technology
  • Life Sciences & Biomedicine
  • Oncology
  • SOX4
  • bladder cancer
  • CRISPR interference
  • invasion
  • WNT5A
  • EXPRESSION
  • GENE
  • TRANSCRIPTION
  • CARCINOMA
  • BREAST
  • MIGRATION
  • APOPTOSIS
  • CRISPR
  • WNT-5A
  • 27-HYDROXYCHOLESTEROL

SOX4 regulates invasion of bladder cancer cells via repression of WNT5a

Tools:

Journal Title:

International Journal of Oncology

Volume:

Volume 55, Number 2

Publisher:

, Pages 359-370

Type of Work:

Article | Final Publisher PDF

Abstract:

Sry-RelatedHMG-BOX-4(SOX4)isadevelopmental transcription factor that is overexpressed in as many as 23% of bladder cancer patients; however, the role of SOX4 in bladder cancer tumorigenesis is not yet well understood. Given the many roles of SOX4 in embryonic development and the context-dependent regulation of gene expression, in this study, we sought to determine the role of SOX4 in bladder cancer and to identify SOX4-regulated genes that may contribute to tumorigenesis. For this purpose, we employed a CRISPR interference (CRISPRi) method to transcriptionally repress SOX4 expression in T24 bladder cancer cell lines, ‘rescued’ these cell lines with the lentiviral-mediated expression of SOX4, and performed whole genome expression profiling. The cells in which SOX4 was knocked down (T24-SOX4-KD) exhibited decreased invasive capabilities, but no changes in migration or proliferation, whereas rescue experiments with SOX4 lentiviral vector restored the invasive phenotype. Gene expression profiling revealed 173 high confidence SOX4-regulated genes, including WNT5a as a potential target of repression by SOX4. Treatment of the T24-SOX4-KD cells with a WNT5a antagonist restored the invasive phenotype observed in the T24-scramble control cells and the SOX4 lentiviral-rescued cells. High WNT5a expression was associated with a decreased invasion and WNT5a expression inversely correlated with SOX4 expression, suggesting that SOX4 can negatively regulate WNT5a levels either directly or indirectly and that WNT5a likely plays a protective role against invasion in bladder cancer cells.

Copyright information:

© 2019 Spandidos Publications. All rights reserved.

This is an Open Access work distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Creative Commons License

Export to EndNote